Provided by Tiger Trade Technology Pte. Ltd.

REMEGEN

73.750
-0.650-0.87%
Volume:2.18M
Turnover:158.78M
Market Cap:41.57B
PE:48.90
High:74.300
Open:73.800
Low:71.750
Close:74.400
52wk High:126.600
52wk Low:63.300
Shares:563.61M
HK Float Shares:208.58M
Volume Ratio:1.03
T/O Rate:1.04%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.508
ROE:109.10%
ROA:39.01%
PB:4.28
PE(LYR):48.90
PS:4.44

Loading ...

Movement Alert|REMEGEN Rises 3.88% in Regular Trading, H1 Earnings Preview Shows Turnaround to Profitability with 47 Billion Yuan Net Profit

Market Focus
·
Aug 10

Hong Kong Stocks in Focus: Remegen Surges Over 5% Before Noon, Achieves First Major Mid-Term Profit Driven by Overseas Licensing

Stock News
·
Aug 07

Movement Alert|REMEGEN Rises 5.03% in Regular Trading, H1 Earnings Swing to Profit with Essential Drug Catalog Catalyst

Market Focus
·
Aug 07

RemeGen Expects to Return to Profit in H1; Hong Kong Shares Down 3%

MT Newswires Live
·
Aug 06

Hong Kong Stock Moves: Remegen Opens Nearly 4% Higher, Anticipates First-Half Net Profit Attributable to Parent of Approximately 4.7 Billion Yuan

Stock News
·
Aug 06

RemeGen forecasts 1H26 net profit of RMB4.70 billion on 433% revenue surge

Bulletin Express
·
Aug 05

RemeGen’s July 2026 Share Update: H-Share Base Steady, A-Share Buyback Trims Free Float by 13,000 Shares

Bulletin Express
·
Aug 04

Remegen Spends Approximately 3.05 Million Yuan to Buy Back 28,000 Shares on August 3

Stock News
·
Aug 03

Hong Kong Stock Movers: Several Innovative Drug Stocks Rally in Afternoon Trading, GENSCRIPT BIO Surges Nearly 8%, REMEGEN Gains Over 4%

Stock News
·
Jul 31

RemeGen repurchases 13,000 A-shares for RMB1.43 million, outstanding share count falls 0.0037%

Bulletin Express
·
Jul 30

Movement Alert|REMEGEN Intraday Decline 5.02%, Ophthalmic Drug RC28-E Registration Apparently Rejected by NMPA

Market Focus
·
Jul 30

Nomura Adjusts RemeGen's Price Target to HK$89.44 From HK$79.64, Keeps at Neutral

MT Newswires Live
·
Jul 27

Movement Alert|REMEGEN Falls 5.1% in Regular Trading, Lock-Up Expiry Selling Pressure Compounded by Biotech Sector Pullback

Market Focus
·
Jul 24

Movement Alert|RemeGen Rises 4.23% in Regular Trading, A-Share Buyback Plan Enters Implementation Phase as Innovative Drug Sector Strengthens

Market Focus
·
Jul 22

Innovative Drug Stocks Rebound Swiftly, Leading ETF Surges as Sector Gains Momentum with Positive Developments from Multiple Companies

Deep News
·
Jul 20

REMEGEN Shares Surge Over 8% on Proposed A-Share Buyback and Positive Outlook for Telitacicept

Stock News
·
Jul 20

RemeGen Proposes Share Buyback of Up to 50 Million Yuan

MT Newswires Live
·
Jul 20

HK Movers | Biomedical Stocks Rally; REMEGEN, WUXI XDC and KEYMED BIO-B Surge Over 8%

Tiger Newspress
·
Jul 20

Hong Kong Stock Connect Biotech Sector Stages Strong Rebound, Key ETF Surges Over 4%; REMEGEN Announces Buyback, Leading Gains

Deep News
·
Jul 20

Hong Kong Stocks Add 2.0% in Morning Trading

Dow Jones
·
Jul 20